| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 1,019.1 | 961.1 |
| Profit before tax | 60.3 | 154.1 |
| Net income | 32.6 | 127.9 |
| EPS (diluted, $ a share) | $0.51 | $1.92 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | -74.5% |
|---|---|
| Revenue, year on year | +6.0% |
| Operating margin | 13.2% |
10-Q filed with the SEC, NYSE: ATR. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Aptargroup, Inc.: key numbers
- Share price
- $143.17Close, Nov 16
- Market cap
- $9.08B
- Shares outstanding
- 63.39MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Plastics Products, NECSIC 3089
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Aptargroup, Inc.
All →Aptargroup Segment President Marc Prieur Sells $284K of Stock
Marc Prieur, Segment President, sold 2,000 shares of Aptargroup, Inc. at $141.99 a share, worth $284K in total on Nov 2, 2026. Shares held after the trade: 13,823 (-12.6%).
- Value
- $284K
- Shares
- 2,000
- Price
- $141.99
- Role
- Segment President
- Holding change
- -12.6%
- Trade date
- Nov 2, 2026
Aptargroup Financial Results
AptarGroup reported third quarter 2026 results with sales increasing 6% to $1.02 billion and adjusted EPS of $1.52. Performance was driven by broad-based revenue growth across all three segments, particularly in Pharma's central nervous system and pulmonary therapies and double-digit core sales growth in Closures.
- Term
- Q3 2026
“We delivered broad-based revenue growth across all three segments. Pharma delivered impressive growth in central nervous system therapies, pulmonary, injectables and consumer healthcare, while maintaining profitability at the high end of our long-term target range.”
Gael Touya, Aptar President and CEO
“As I begin my tenure as CEO, our direction is clear: deepen our position with customers, accelerate innovation, execute with greater consistency and allocate capital thoughtfully. These priorities will guide how we drive profitable growth and create long-term value for Aptar and our shareholders.”
Gael Touya, Aptar President and CEO
Aptargroup Other 8-K Filing
AptarGroup's Russian subsidiary, OOO Aptar Vladimir, has been placed under temporary external administration by a decree from the President of the Russian Federation. The company is assessing its options and legal rights regarding the subsidiary, which accounted for less than 0.6% of consolidated net sales and operating income as of late 2025. This event represents a loss of operational control over Russian assets due to geopolitical actions.
- Counterparty
- OOO Aptar Vladimir